1 |
Smyth EC, Nilsson M, Grabsch HI, et al. Gastric cancer[J]. Lancet, 2020, 396(10251): 635-48. DOI: 10.1016/s0140-6736(20)31288-5
|
2 |
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-49. DOI: 10.3322/caac.21660
|
3 |
Xia CF, Dong XS, Li H, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants[J]. Chin Med J, 2022, 135(5): 584-90. DOI: 10.1097/cm9.0000000000002108
|
4 |
Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods[J]. Int J Cancer, 2019, 144(8): 1941-53. DOI: 10.1002/ijc.31937
|
5 |
Zhang KC, Chen L. Chinese consensus on the diagnosis and treatment of gastric cancer with liver metastases[J]. Ther Adv Med Oncol, 2020, 12: 1758835920904803. DOI: 10.1177/1758835920904803
|
6 |
Tan ZY. Recent advances in the surgical treatment of advanced gastric cancer: a review[J]. Med Sci Monit, 2019, 25: 3537-41. DOI: 10.12659/msm.916475
|
7 |
Yang YQ, Ma YF, Xiang XY, et al. The prognostic value of the lymph node ratio for local advanced gastric cancer patients with intensity-modulated radiation therapy and concurrent chemotherapy after radical gastrectomy in China[J]. Radiat Oncol, 2020, 15(1): 237. DOI: 10.1186/s13014-020-01687-0
|
8 |
Nakayama I, Takahari D. The role of angiogenesis targeted therapies in metastatic advanced gastric cancer: a narrative review[J]. J Clin Med, 2023, 12(9): 3226. DOI: 10.3390/jcm12093226
|
9 |
Lin JX, Lian NZ, Gao YX, et al. m6A methylation mediates LHPP acetylation as a tumour aerobic glycolysis suppressor to improve the prognosis of gastric cancer[J]. Cell Death Dis, 2022, 13(5): 463. DOI: 10.1038/s41419-022-04859-w
|
10 |
Zhao HY, Jiang RK, Feng ZJ, et al. Transcription factor LHX9 (LIM Homeobox 9) enhances pyruvate kinase PKM2 activity to induce glycolytic metabolic reprogramming in cancer stem cells, promoting gastric cancer progression[J]. J Transl Med, 2023, 21(1): 833. DOI: 10.1186/s12967-023-04658-7
|
11 |
Pouysségur J, Marchiq I, Parks SK, et al. ‘Warburg effect' controls tumor growth, bacterial, viral infections and immunity-Genetic deconstruction and therapeutic perspectives[J]. Semin Cancer Biol, 2022, 86(Pt 2): 334-46. DOI: 10.1016/j.semcancer.2022.07.004
|
12 |
Jonckheere AI, Smeitink JAM, Rodenburg RJT. Mitochondrial ATP synthase: architecture, function and pathology[J]. J Inherit Metab Dis, 2012, 35(2): 211-25. DOI: 10.1007/s10545-011-9382-9
|
13 |
Jana S, Heaven MR, Stauft CB, et al. HIF-1α-dependent metabolic reprogramming, oxidative stress, and bioenergetic dysfunction in SARS-CoV-2-infected hamsters[J]. Int J Mol Sci, 2022, 24(1): 558. DOI: 10.3390/ijms24010558
|
14 |
Li JB, Wang JZ, Pan TH, et al. USP25 deficiency promotes T cell dysfunction and transplant acceptance via mitochondrial dynamics[J]. Int Immunopharmacol, 2023, 117: 109917. DOI: 10.1016/j.intimp.2023.109917
|
15 |
梁亚敏. TET2/ATP5A1在低剪切应力诱导内皮间质转化中的作用及机制研究[D]. 衡阳: 南华大学, 2022.
|
16 |
Ba YS, Ma FW, Ma YW, et al. ATP5A1 participates in transcriptional and posttranscriptional regulation of cancer-associated genes by modulating their expression and alternative splicing profiles in HeLa cells[J]. Technol Cancer Res Treat, 2021, 20: 15330338211039126. DOI: 10.1177/15330338211039126
|
17 |
Pan J, Sun LC, Tao YF, et al. ATP synthase ecto-α-subunit: a novel therapeutic target for breast cancer[J]. J Transl Med, 2011, 9: 211. DOI: 10.1186/1479-5876-9-211
|
18 |
杨素丽. ATP5A1在大肠癌中的表达及其临床意义[D]. 长春: 吉林大学, 2017.
|
19 |
Li M, Wang M, Xi Y, et al. Isolation and identification of a Tibetan pig porcine epidemic diarrhoea virus strain and its biological effects on IPEC-J2 cells[J]. Int J Mol Sci, 2024, 25(4): 2200. DOI: 10.3390/ijms25042200
|
20 |
Choi Y, Park J, Choi Y, et al. C-Jun N-terminal kinase activation has a prognostic implication and is negatively associated with FOXO1 activation in gastric cancer[J]. BMC Gastroenterol, 2016, 16(1): 59. DOI: 10.1186/s12876-016-0473-9
|
21 |
Zhang L, Gao YG. ICOSLG acts as an oncogene to promote glycolysis, proliferation, migration, and invasion in gastric cancer cells[J]. Arch Biochem Biophys, 2024, 752: 109841. DOI: 10.1016/j.abb.2023.109841
|
22 |
Peng CZ, Yang X, Li X, et al. ALDOB plays a tumor-suppressive role by inhibiting AKT activation in gastric cancer[J]. J Cancer, 2023, 14(12): 2255-62. DOI: 10.7150/jca.83456
|
23 |
Xu GY, Li JY. ATP5A1 and ATP5B are highly expressed in glioblastoma tumor cells and endothelial cells of microvascular proliferation[J]. J Neurooncol, 2016, 126(3): 405-13. DOI: 10.1007/s11060-015-1984-x
|
24 |
Yuan LS, Chen L, Qian KY, et al. A novel correlation between ATP5A1 gene expression and progression of human clear cell renal cell carcinoma identified by co-expression analysis[J]. Oncol Rep, 2018, 39(2): 525-36.
|
25 |
Martínez-Esquivias F, Gutiérrez-Angulo M, Becerra-Ruiz JS, et al. Bioinformatic analysis of the effect of silver nanoparticles on colorectal cancer cell line[J]. Biomed Res Int, 2022, 2022: 6828837. DOI: 10.1155/2022/6828837
|
26 |
Zhang GF, Zhong JM, Lin L, et al. Loss of ATP5A1 enhances proliferation and predicts poor prognosis of colon adenocarcinoma[J]. Pathol Res Pract, 2022, 230: 153679. DOI: 10.1016/j.prp.2021.153679
|
27 |
Bose S, Zhang C, Le A. Glucose metabolism in cancer: the Warburg effect and beyond[J]. Adv Exp Med Biol, 2021, 1311: 3-15. DOI: 10.1007/978-3-030-65768-0_1
|
28 |
Liberti MV, Locasale JW. The Warburg effect: how does it benefit cancer cells?[J]. Trends Biochem Sci, 2016, 41(3): 211-8. DOI: 10.1016/j.tibs.2015.12.001
|
29 |
Yang HL, Lin PY, Vadivalagan C, et al. Coenzyme Q0 defeats NLRP3-mediated inflammation, EMT/metastasis, and Warburg effects by inhibiting HIF-1α expression in human triple-negative breast cancer cells[J]. Arch Toxicol, 2023, 97(4): 1047-68. DOI: 10.1007/s00204-023-03456-w
|
30 |
Mi YS, Li QH, Liu BT, et al. Ubiquitous mitochondrial creatine kinase promotes the progression of gastric cancer through a JNK-MAPK/JUN/HK2 axis regulated glycolysis[J]. Gastric Cancer, 2023, 26(1): 69-81. DOI: 10.1007/s10120-022-01340-7
|